Delayed enhancement magnetic resonance imaging is a significant prognostic factor in patients with non-ischemic cardiomyopathy

Circulation Journal

Volumn 74, Issue 3, 2010, Pages 476-483

  Cho, Jung Rae ^a   Park, Sungha ^b   Choi, Byoung Wook ^b   Kang, Seok Min ^b   Ha, Jong Won ^b   Chung, Namsik ^b   Choe, Kyu Ok ^b   Cho, Seung Yun ^b   Rim, Se Joong ^b  

^a Hallym University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Delayed enhancement; Heart failure; Magnetic resonance imaging; Non ischemic cardiomyopathy; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EVENT FREE SURVIVAL; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON ISCHEMIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTOR VARIABLE; PROGNOSIS;

ADULT; AGED; CARDIOMYOPATHIES; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE VOLUME;

EID: 77649226322     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0446     Document Type: Article

References (22)

1. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
2. Wagner A, Mahholdt H, Holy T. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 2003; 361: 374-379.
3. Park S, Choi BW, Rim SJ, Shim CY, Ko YG, Kang SM, et al. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction. J Card Fail 2006; 12: 93-99.
4. Zannad F, Alla F, Dousset B, Perez A, Pitt B, Rales Investigators. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spirinolactone therapy in patients with congestive heart failure: Insights from the Randomized ALdactone Evaluation Study (RALES). Circulation 2000; 102: 2700-2706.
5. Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999; 99: 2750-2756.
6. Miura K, Matsumori A, Nasermoaddeli A, Soyama Y, Morikawa Y, Sakurai M, et al. Prognosis and prognostic factors in patients with idiopathic dilated cardiomyopathy in Japan: Results from a nationwide study. Circ J 2008; 72: 343-348.
7. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients. Am J Cardiol 1987; 60: 1340-1355.
8. American Society of Echocardiography. Committee on standards, subcommittee on quantitation of two dimensional echocardiograms: Recommendations for quantitation of the left ventricle by twodimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 361-367.
9. Kim RJ, Chen EL, Lima JAC, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94: 3318-3326.
10. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-28.
11. Moon JCC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003; 41: 1561-1567.
12. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadoliniumenhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54-59.
13. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003; 108: 1945-1953.
14. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985.
15. Nanjo S, Yoshikawa K, Harada M, Inoue Y, Namiki A, Nakano H, et al. Correlation between left ventricular diastolic function and ejection fraction in dilated cardiomyopathy using magnetic resonance imaging with late gadolinium enhancement. Circ J 2009; 73: 1939-1943.
16. Zimmermann O, Grebe O, Merkle N, Nusser T, Kochs M, Bienek-Ziolkowski M, et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail 2006; 8: 162-166.
17. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 112: 154-235.
18. Cicoira M, Zanolla L, Latina L, Rossi A, Golia G, Brighetti G, et al. Frequency, prognosis and predictors of systolic left ventricular function in patients with 'classical' clinical diagnosis of idiopathic dilated cardiomyopathy. Eur J Heart Fail 2001; 3: 323-330.
19. Teragaki M, Takeuchi K, Takeda T. Clinical and histologic features of alcohol drinkers with congestive heart failure. Am Heart J 1993; 125: 808-817.
20. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Carvedilol Prospective Randomized Cumulative Survival Study Group: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
21. Lechat P, Escolano S, Golmard JL, Lardoux H, Witchitz S, Henneman JA, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation 1997; 96: 2197-2205.
22. Cleland JG, Pennell DJ, Ray SG, Coats AJ, Macfarlane PW, Murray GD, et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure: The CHRISTMAS trial. Lancet 2003; 362: 14-21.